首页 > 最新文献

Iranian journal of kidney diseases最新文献

英文 中文
Microvesicles from Mesenchymal Stem Cells Overexpressing MiR-34a Ameliorate Renal Fibrosis In Vivo. 过表达 MiR-34a 的间充质干细胞微囊可改善体内肾脏纤维化
IF 1.3 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-04-25 DOI: 10.5254/s9bdqs74
Yan Wang, Ping Hu, Yangping Li, Ruijuan Dong, Juan He
We recently discovered that microvesicles (MVs) derived from mesenchymal stem cells (MSCs) overexpressing miRNA-34a can alleviate experimental kidney injury in mice. In this study, we further explored the effects of miR34a-MV on renal fibrosis in the unilateral ureteral obstruction (UUO) models. Methods. Bone marrow MSCs were modified by lentiviruses overexpressing miR-34a, and MVs were collected from the supernatants of MSCs. C57BL6/J mice were divided into control, unilateral ureteral obstruction (UUO), UUO + MV, UUO + miR-34aMV and UUO + miR-34a-inhibitor-MV groups. MVs were injected to mice after surgery. The mice were then euthanized on day 7 and 14 of modeling, and renal tissues were collected for further analyses by Hematoxylin and eosin, Masson's trichrome, and Immunohistochemical (IHC) staining. Results. The UUO + MV group exhibited a significantly reduced degree of renal interstitial fibrosis with inflammatory cell infiltration, tubular epithelial cell atrophy, and vacuole degeneration compared with the UUO group. Surprisingly, overexpressing miR-34a enhanced these effects of MSC-MV on the UUO mice. Conclusion. Our study demonstrates that miR34a further enhances the effects of MSC-MV on renal fibrosis in mice through the regulation of epithelial-to-mesenchymal transition (EMT) and Notch pathway. miR-34a may be a candidate molecular therapeutic target for the treatment of renal fibrosis. DOI: 10.52547/ijkd.7673.
我们最近发现,间充质干细胞(MSCs)过度表达 miRNA-34a 后产生的微囊泡(MVs)可减轻小鼠的实验性肾损伤。在本研究中,我们进一步探讨了 miR34a-MV 对单侧输尿管梗阻(UUO)模型肾纤维化的影响。研究方法用过表达 miR-34a 的慢病毒修饰骨髓间充质干细胞,从间充质干细胞上清液中收集 MV。将 C57BL6/J 小鼠分为对照组、单侧输尿管梗阻(UUO)组、UUO + MV 组、UUO + miR-34aMV 组和 UUO + miR-34a 抑制剂-MV 组。手术后向小鼠注射 MV。然后在建模第 7 天和第 14 天对小鼠实施安乐死,并收集肾组织,通过苏木精和伊红、Masson 三色和免疫组织化学(IHC)染色进行进一步分析。结果与 UUO 组相比,UUO + MV 组的肾间质纤维化程度明显减轻,并伴有炎性细胞浸润、肾小管上皮细胞萎缩和空泡变性。令人惊讶的是,过表达 miR-34a 能增强间充质干细胞-间充质干细胞对 UUO 小鼠的上述作用。结论我们的研究表明,miR34a通过调控上皮细胞向间质转化(EMT)和Notch通路,进一步增强了间充质干细胞-MV对小鼠肾脏纤维化的影响,miR-34a可能是治疗肾脏纤维化的候选分子治疗靶点。DOI: 10.52547/ijkd.7673.
{"title":"Microvesicles from Mesenchymal Stem Cells Overexpressing MiR-34a Ameliorate Renal Fibrosis In Vivo.","authors":"Yan Wang, Ping Hu, Yangping Li, Ruijuan Dong, Juan He","doi":"10.5254/s9bdqs74","DOIUrl":"https://doi.org/10.5254/s9bdqs74","url":null,"abstract":"We recently discovered that microvesicles (MVs) derived from mesenchymal stem cells (MSCs) overexpressing miRNA-34a can alleviate experimental kidney injury in mice. In this study, we further explored the effects of miR34a-MV on renal fibrosis in the unilateral ureteral obstruction (UUO) models. Methods. Bone marrow MSCs were modified by lentiviruses overexpressing miR-34a, and MVs were collected from the supernatants of MSCs. C57BL6/J mice were divided into control, unilateral ureteral obstruction (UUO), UUO + MV, UUO + miR-34aMV and UUO + miR-34a-inhibitor-MV groups. MVs were injected to mice after surgery. The mice were then euthanized on day 7 and 14 of modeling, and renal tissues were collected for further analyses by Hematoxylin and eosin, Masson's trichrome, and Immunohistochemical (IHC) staining. Results. The UUO + MV group exhibited a significantly reduced degree of renal interstitial fibrosis with inflammatory cell infiltration, tubular epithelial cell atrophy, and vacuole degeneration compared with the UUO group. Surprisingly, overexpressing miR-34a enhanced these effects of MSC-MV on the UUO mice. Conclusion. Our study demonstrates that miR34a further enhances the effects of MSC-MV on renal fibrosis in mice through the regulation of epithelial-to-mesenchymal transition (EMT) and Notch pathway. miR-34a may be a candidate molecular therapeutic target for the treatment of renal fibrosis. DOI: 10.52547/ijkd.7673.","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"9 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140801461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mind the Gap in Kidney Care: Translating What We Know Into What We Do. 关注肾脏护理中的差距:将我们的知识转化为我们的行动。
IF 1.3 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-04-25 DOI: 10.5254/sqbbj216
Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, Or The World Kidney Day Joint Steering Committee
Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay. DOI: 10.52547/ijkd.8216.
从历史上看,新疗法从临床证据转化为日常实践平均需要 17 年的时间。鉴于目前已有的高效疗法可以预防或延缓肾病的发生和发展,这个时间太长了。现在是缩小我们所知道的与我们所做的之间差距的时候了。对于高血压和糖尿病等肾脏病常见风险因素的预防和管理,已有明确的指导方针,但全世界只有一小部分肾脏病患者被确诊,接受目标治疗的患者则更少。同样,绝大多数肾病患者都不知道自己的病情,因为肾病在早期往往是无声无息的。即使在已经确诊的患者中,许多人也没有接受适当的肾病治疗。考虑到肾病恶化、肾衰竭或死亡的严重后果,必须及早开始适当的治疗。必须从初级保健开始,最大限度地利用早期诊断和治疗肾病的机会。从患者到临床医生,从医疗系统到社会因素,存在着许多系统性障碍。为了维护和改善世界各地每个人的肾脏健康,必须认识到这些障碍中的每一个,以便制定和实施可持续的解决方案,不再拖延。DOI: 10.52547/ijkd.8216.
{"title":"Mind the Gap in Kidney Care: Translating What We Know Into What We Do.","authors":"Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, Or The World Kidney Day Joint Steering Committee","doi":"10.5254/sqbbj216","DOIUrl":"https://doi.org/10.5254/sqbbj216","url":null,"abstract":"Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay. DOI: 10.52547/ijkd.8216.","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"50 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140806280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor. PD-1/PD-L1抑制剂治疗的原发性非小细胞肺癌患者发生AKI的风险因素分析
IF 1.3 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-04-25 DOI: 10.5254/0n3xpz60
Jiong-Ming Ying, Feng Yan
To investigate the risk factors of Programmed Cell Death Protein 1 (PD-1), Programmed Cell Death Ligand 1(PD-L1) inhibitor associated acute kidney injury (AKI) in patients with primary non-small cell lung cancer (NSCLC) and construct a predictive model.
研究原发性非小细胞肺癌(NSCLC)患者中程序性细胞死亡蛋白1(PD-1)、程序性细胞死亡配体1(PD-L1)抑制剂相关急性肾损伤(AKI)的风险因素,并构建预测模型。
{"title":"Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor.","authors":"Jiong-Ming Ying, Feng Yan","doi":"10.5254/0n3xpz60","DOIUrl":"https://doi.org/10.5254/0n3xpz60","url":null,"abstract":"To investigate the risk factors of Programmed Cell Death Protein 1 (PD-1), Programmed Cell Death Ligand 1(PD-L1) inhibitor associated acute kidney injury (AKI) in patients with primary non-small cell lung cancer (NSCLC) and construct a predictive model.","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"25 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140801439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation Between the 8-hydroxy-2'-deoxyguanosine Level in the Peritoneal Solution of Patients Undergoing Peritoneal Dialysis and the Peritoneal Equilibration Test, Kt/V, Ferritin, and Albumin Levels. 腹膜透析患者腹腔液中 8- 羟基-2'-脱氧鸟苷水平与腹膜平衡试验、Kt/V、铁蛋白和白蛋白水平之间的相关性。
IF 1.3 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-04-25 DOI: 10.5254/fte08z03
Hadi Khanifar, Leila Mahmoodnia
Peritoneal dialysis (PD) is an effective treatment modality for advanced kidney failure, offering patients a significant degree of independence. However, the long-term use of PD is limited due to the degeneration of the peritoneal membrane, resulting in reduced dialysis adequacy. Evaluating the peritoneal membrane condition in patients with advanced kidney failure who are undergoing PD is challenging with existing methods. Therefore, this study aimed to investigate the correlation between 8-hydroxy-2'-deoxyguanosine (8OHDG) levels in the peritoneal solution of patients undergoing PD and various factors, such as peritoneal equilibration test (PET), dialysis adequacy (Kt/V), underlying diseases, serum ferritin, and albumin levels. 8OHDG is a sensitive marker of oxidative stress caused by DNA damage.
腹膜透析(PD)是晚期肾衰竭的一种有效治疗方式,可为患者提供很大程度的独立性。然而,由于腹膜退化导致透析充分性降低,腹膜透析的长期使用受到限制。使用现有方法评估接受腹膜透析的晚期肾衰竭患者的腹膜状况具有挑战性。因此,本研究旨在探讨腹膜透析患者腹腔溶液中 8- 羟基-2'-脱氧鸟苷(8OHDG)水平与腹膜平衡试验(PET)、透析充分性(Kt/V)、基础疾病、血清铁蛋白和白蛋白水平等各种因素之间的相关性。8OHDG 是 DNA 损伤导致氧化应激的敏感标记。
{"title":"Correlation Between the 8-hydroxy-2'-deoxyguanosine Level in the Peritoneal Solution of Patients Undergoing Peritoneal Dialysis and the Peritoneal Equilibration Test, Kt/V, Ferritin, and Albumin Levels.","authors":"Hadi Khanifar, Leila Mahmoodnia","doi":"10.5254/fte08z03","DOIUrl":"https://doi.org/10.5254/fte08z03","url":null,"abstract":"Peritoneal dialysis (PD) is an effective treatment modality for advanced kidney failure, offering patients a significant degree of independence. However, the long-term use of PD is limited due to the degeneration of the peritoneal membrane, resulting in reduced dialysis adequacy. Evaluating the peritoneal membrane condition in patients with advanced kidney failure who are undergoing PD is challenging with existing methods. Therefore, this study aimed to investigate the correlation between 8-hydroxy-2'-deoxyguanosine (8OHDG) levels in the peritoneal solution of patients undergoing PD and various factors, such as peritoneal equilibration test (PET), dialysis adequacy (Kt/V), underlying diseases, serum ferritin, and albumin levels. 8OHDG is a sensitive marker of oxidative stress caused by DNA damage.","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"145 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140801530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误。
IF 0.7 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-03-01 DOI: 10.52547/ijkd.8206
Admin Admin
{"title":"Erratum.","authors":"Admin Admin","doi":"10.52547/ijkd.8206","DOIUrl":"10.52547/ijkd.8206","url":null,"abstract":"","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"18 2","pages":"136"},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptual Approach to Body Fluids and Edema, Education Determines Clinical Outcomes in Heart Failure. 体液和水肿的概念方法,教育决定心力衰竭的临床结果。
IF 0.8 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-03-01 DOI: 10.52547/ijkd.8171
Mohammad A Shafiee, Amireza Goli, Pouyan Shaker, Vishal Sharma, Yasmin Shahideh, Khrystyna Maryniak, Behrooz Broumand

In this brief communication, we reemphasize the importance of critical thinking in clinical practice using the example of edema. The common practice of thinking and inquiry by practicing clinicians has beneficial implications for healthcare by improving outcomes and patient care while alleviating the burden of misconceptions in practice. We provide an in-depth and interactive investigation of physiological concepts as a foundation for understanding body fluid dynamics. Finally, we offer a new classification of symptoms of heart failure. DOI: 10.52547/ijkd.8171.

在这篇简短的通讯中,我们以水肿为例,再次强调批判性思维在临床实践中的重要性。临床医生普遍的思考和探究实践对医疗保健具有有益的影响,既能改善治疗效果和患者护理,又能减轻实践中的误解负担。我们对生理概念进行了深入的互动式探究,以此作为理解体液动力学的基础。最后,我们对心力衰竭的症状进行了新的分类。DOI: 10.52547/ijkd.8171.
{"title":"Conceptual Approach to Body Fluids and Edema, Education Determines Clinical Outcomes in Heart Failure.","authors":"Mohammad A Shafiee, Amireza Goli, Pouyan Shaker, Vishal Sharma, Yasmin Shahideh, Khrystyna Maryniak, Behrooz Broumand","doi":"10.52547/ijkd.8171","DOIUrl":"https://doi.org/10.52547/ijkd.8171","url":null,"abstract":"<p><p>In this brief communication, we reemphasize the importance of critical thinking in clinical practice using the example of edema. The common practice of thinking and inquiry by practicing clinicians has beneficial implications for healthcare by improving outcomes and patient care while alleviating the burden of misconceptions in practice. We provide an in-depth and interactive investigation of physiological concepts as a foundation for understanding body fluid dynamics. Finally, we offer a new classification of symptoms of heart failure. DOI: 10.52547/ijkd.8171.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"18 2","pages":"65-67"},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor. PD-1/PD-L1抑制剂治疗的原发性非小细胞肺癌患者发生AKI的风险因素分析
IF 0.8 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-03-01 DOI: 10.52547/ijkd.7964
Jiong-Ming Ying, Feng Yan

Introduction: To investigate the risk factors of Programmed Cell Death Protein 1 (PD-1), Programmed Cell Death Ligand 1(PD-L1) inhibitor associated acute kidney injury (AKI) in patients with primary non-small cell lung cancer (NSCLC) and construct a predictive model.

Methods: 120 NSCLC patients were selected as the research subjects and their clinical data were collected. Patients were divided into AKI and Non-AKI (N-AKI) group based on the development of AKI. Exploring the risk factors of PD-1P/D-L1 inhibitor related AKI in NSCLC patients using multivariate logistic regression analysis and visualized the logistic regression analysis to obtain a nomogram model. Meanwhile, evaluate the predictive value of the model.

Results: The results of multivariate analysis showed that the presence of extrarenal immune related adverse reactions (irAEs) is a risk factor for PD-1/PD-L1 inhibitor related AKI in NSCLC patients; At the same time, the risk of developing PD-1/PD-L1 inhibitor related AKI in NSCLC patients increases with increasing serum creatinine (SCr) and C-reactive protein (CRP) levels, decreasing baseline estimated glomerular filtration rate (eGFR) levels (P < .05). The analysis results of receiver operator characteristic curve (ROC), calibration curve, and decision curve show that the model has good discrimination and accuracy, and can achieve a high clinical benefit rate.

Conclusion: Primary NSCLC patients with extrarenal irAEs, high levels of SCr and CRP, and low levels of eGFR have a higher risk of AKI after PD-1/PD-L1 inhibitor treatment. Establishing a predictive model with high accuracy is more conducive to early detection of high-risk patients. DOI: 10.52547/ijkd.7964.

简介研究原发性非小细胞肺癌(NSCLC)患者程序性细胞死亡蛋白1(PD-1)、程序性细胞死亡配体1(PD-L1)抑制剂相关急性肾损伤(AKI)的风险因素,并构建预测模型。方法:选取 120 例 NSCLC 患者作为研究对象,收集他们的临床数据,根据 AKI 的发生情况将患者分为 AKI 组和非 AKI 组(N-AKI)。利用多变量逻辑回归分析探讨NSCLC患者PD-1P/D-L1抑制剂相关AKI的风险因素,并将逻辑回归分析结果可视化,得到提名图模型。同时,评估模型的预测价值:多变量分析结果显示,肾外免疫相关不良反应(irAEs)是NSCLC患者发生PD-1/PD-L1抑制剂相关性AKI的危险因素;同时,NSCLC患者发生PD-1/PD-L1抑制剂相关性AKI的风险随着血清肌酐(SCr)和C反应蛋白(CRP)水平的升高、基线估计肾小球滤过率(eGFR)水平的降低而增加(P<0.05)。接收者运算特征曲线(ROC)、校准曲线和决策曲线的分析结果表明,该模型具有良好的区分度和准确性,可获得较高的临床获益率:结论:PD-1/PD-L1抑制剂治疗后,肾外irAEs、SCr和CRP水平高、eGFR水平低的原发性NSCLC患者发生AKI的风险较高。建立高精度的预测模型更有利于早期发现高危患者。DOI: 10.52547/ijkd.7964.
{"title":"Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor.","authors":"Jiong-Ming Ying, Feng Yan","doi":"10.52547/ijkd.7964","DOIUrl":"https://doi.org/10.52547/ijkd.7964","url":null,"abstract":"<p><strong>Introduction: </strong>To investigate the risk factors of Programmed Cell Death Protein 1 (PD-1), Programmed Cell Death Ligand 1(PD-L1) inhibitor associated acute kidney injury (AKI) in patients with primary non-small cell lung cancer (NSCLC) and construct a predictive model.</p><p><strong>Methods: </strong>120 NSCLC patients were selected as the research subjects and their clinical data were collected. Patients were divided into AKI and Non-AKI (N-AKI) group based on the development of AKI. Exploring the risk factors of PD-1P/D-L1 inhibitor related AKI in NSCLC patients using multivariate logistic regression analysis and visualized the logistic regression analysis to obtain a nomogram model. Meanwhile, evaluate the predictive value of the model.</p><p><strong>Results: </strong>The results of multivariate analysis showed that the presence of extrarenal immune related adverse reactions (irAEs) is a risk factor for PD-1/PD-L1 inhibitor related AKI in NSCLC patients; At the same time, the risk of developing PD-1/PD-L1 inhibitor related AKI in NSCLC patients increases with increasing serum creatinine (SCr) and C-reactive protein (CRP) levels, decreasing baseline estimated glomerular filtration rate (eGFR) levels (P < .05). The analysis results of receiver operator characteristic curve (ROC), calibration curve, and decision curve show that the model has good discrimination and accuracy, and can achieve a high clinical benefit rate.</p><p><strong>Conclusion: </strong>Primary NSCLC patients with extrarenal irAEs, high levels of SCr and CRP, and low levels of eGFR have a higher risk of AKI after PD-1/PD-L1 inhibitor treatment. Establishing a predictive model with high accuracy is more conducive to early detection of high-risk patients. DOI: 10.52547/ijkd.7964.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"18 2","pages":"108-117"},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis of Peritoneal Dialysis Patients with Different Peritoneal Transport Characteristics: A Retrospective Cohort Study. 腹膜透析患者不同腹膜运输特征的预后:一项回顾性队列研究
IF 0.8 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.52547/ijkd.7617
Yangyang Xia, Chunming Jiang, Ying Liu, Qingyan Zhang, Yuan Feng, Miao Zhang

Introduction: We aimed to examine the clinical characteristics of peritoneal dialysis (PD) patients with different baseline peritoneal transport characteristics and the effect of peritoneal transport characteristics on the prognosis of PD patients.

Methods: Patients who received PD for more than 3 months were included. Clinical characteristics, risk factors for high peritoneal transport, and risk factors for death and technique failure were examined. All patients were treated with glucose-containing peritoneal dialysis solution, and the peritoneal dialysis protocol was either day ambulatory peritoneal dialysis (DAPD) or continuous ambulatory peritoneal dialysis (CAPD).

Results: A total of 351 patients were enrolled, comprising 70 in the low transport group, 149 in the low average transport group, 88 in the high average transport group, and 44 in the high transport group. Multivariate logistic regression analysis showed that a high Charlson's comorbidity index (CCI) and low albumin were risk factors for a high baseline transport status. In the nonhigh transport group, the proportion of patients with albumin less than 30 g/L, who developed high transport status, was higher than those with albumin more than 30 g/L (P = .029). The survival rate in the high transport group was significantly lower than that in the other three groups (P < .001). Multivariate Cox regression analysis showed that age, systolic blood pressure, CCI, C-reactive protein (CRP) and high transport were independent risk factors for all-cause mortality. Male sex, triglycerides and CRP were independent risk factors for technique failure.

Conclusion: High peritoneal transport status is an independent risk factor for death. High CCI and low albumin are determinants of baseline high peritoneal transport. To avoid development of a high transport state, serum albumin should be increased to more than 30 g/L.

简介:我们的目的是研究具有不同基线腹膜转运特征的腹膜透析(PD)患者的临床特征以及腹膜转运特征对 PD 患者预后的影响:我们旨在研究腹膜透析(PD)患者不同基线腹膜转运特征的临床特点,以及腹膜转运特征对腹膜透析患者预后的影响:方法:纳入接受腹膜透析超过 3 个月的患者。方法:纳入接受腹膜透析治疗 3 个月以上的患者,研究其临床特征、高腹膜运输风险因素以及死亡和技术失败的风险因素。所有患者均接受含葡萄糖的腹膜透析液治疗,腹膜透析方案为日间非卧床腹膜透析(DAPD)或连续非卧床腹膜透析(CAPD):共有 351 名患者入选,其中低转运组 70 人,低平均转运组 149 人,高平均转运组 88 人,高转运组 44 人。多变量逻辑回归分析显示,夏尔森合并症指数(CCI)高和白蛋白低是基线转运率高的风险因素。在非高转运组中,白蛋白低于 30 g/L 的患者出现高转运状态的比例高于白蛋白高于 30 g/L 的患者(P = .029)。高转运组的存活率明显低于其他三组(P < .001)。多变量 Cox 回归分析表明,年龄、收缩压、CCI、C 反应蛋白(CRP)和高运输量是全因死亡率的独立风险因素。男性、甘油三酯和CRP是技术失败的独立危险因素:结论:高腹膜转运状态是导致死亡的独立风险因素。高 CCI 和低白蛋白是基线高腹膜运输的决定因素。为避免出现高转运状态,应将血清白蛋白提高到 30 克/升以上。 DOI: 10.52547/ijkd.7617.
{"title":"Prognosis of Peritoneal Dialysis Patients with Different Peritoneal Transport Characteristics: A Retrospective Cohort Study.","authors":"Yangyang Xia, Chunming Jiang, Ying Liu, Qingyan Zhang, Yuan Feng, Miao Zhang","doi":"10.52547/ijkd.7617","DOIUrl":"10.52547/ijkd.7617","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to examine the clinical characteristics of peritoneal dialysis (PD) patients with different baseline peritoneal transport characteristics and the effect of peritoneal transport characteristics on the prognosis of PD patients.</p><p><strong>Methods: </strong>Patients who received PD for more than 3 months were included. Clinical characteristics, risk factors for high peritoneal transport, and risk factors for death and technique failure were examined. All patients were treated with glucose-containing peritoneal dialysis solution, and the peritoneal dialysis protocol was either day ambulatory peritoneal dialysis (DAPD) or continuous ambulatory peritoneal dialysis (CAPD).</p><p><strong>Results: </strong>A total of 351 patients were enrolled, comprising 70 in the low transport group, 149 in the low average transport group, 88 in the high average transport group, and 44 in the high transport group. Multivariate logistic regression analysis showed that a high Charlson's comorbidity index (CCI) and low albumin were risk factors for a high baseline transport status. In the nonhigh transport group, the proportion of patients with albumin less than 30 g/L, who developed high transport status, was higher than those with albumin more than 30 g/L (P = .029). The survival rate in the high transport group was significantly lower than that in the other three groups (P < .001). Multivariate Cox regression analysis showed that age, systolic blood pressure, CCI, C-reactive protein (CRP) and high transport were independent risk factors for all-cause mortality. Male sex, triglycerides and CRP were independent risk factors for technique failure.</p><p><strong>Conclusion: </strong>High peritoneal transport status is an independent risk factor for death. High CCI and low albumin are determinants of baseline high peritoneal transport. To avoid development of a high transport state, serum albumin should be increased to more than 30 g/L.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"1 1","pages":"56-64"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Anthropometric Indices with Albumin to Creatinine Ratio and Glomerular Filtration Rate, as Indices of CKD: A Population-based Study. 作为慢性肾脏病指标的人体测量指标与白蛋白肌酐比值和肾小球滤过率的关系:一项基于人群的研究。
IF 0.8 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.52547/ijkd.7685
Firouzeh Moinzadeh, Media Babahajiani, Marjan Mansourian, Hourinaz Taghvaee

Introduction: This study was an attempt to detect the relationship between chronic kidney disease (CKD) and anthropometric indices in presence of confounding variables.

Methods: A cross-sectional study of 3375 participants was designed in Isfahan city. Waist-height ratio (WHtR), waist-hip ratio (WHR), body mass index (BMI) and waist circumference (WC) were measured. Participants were divided into CKD and non-CKD groups according to the calculated albumin to creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). Then, the groups were subdivided into sub-groups of high and normal anthropometric indices.

Results: To evaluate CKD in relation to anthropometric indices, odds ratio was calculated; in the female group, no association was observed (P ˃ .05). However, in the male group high levels of WHtR and BMI were associated with CKD (P value of .002 and .015, respectively). To evaluate the association between ACR and eGFR with anthropometric indices linear regression analysis was performed. There was no significant relation between ACR and eGFR with anthropometric indices in both sexes in a fully adjusted state (P ˃ .05).

Conclusion: High WHtR and BMI probably are associated with CKD in male. WHR and WC have no relation to the occurrence of CKD. There are no significant changes in regard to ACR and eGFR.

导言:本研究试图检测慢性肾脏病(CKD)与人体测量指数之间的关系:本研究试图在存在混杂变量的情况下,检测慢性肾脏病(CKD)与人体测量指数之间的关系:在伊斯法罕市对 3375 名参与者进行了横断面研究。研究测量了腰高比(WHtR)、腰臀比(WHR)、体重指数(BMI)和腰围(WC)。根据计算得出的白蛋白与肌酐比率(ACR)和估计肾小球滤过率(eGFR),将参与者分为慢性阻塞性肺病组和非慢性阻塞性肺病组。然后,各组又细分为人体测量指数高和正常的亚组:为了评估慢性肾功能衰竭与人体测量指数的关系,计算了几率比;在女性组中,没有观察到相关性(P ˃.05)。然而,在男性组中,高水平的 WHtR 和 BMI 与 CKD 相关(P 值分别为 .002 和 .015)。为了评估 ACR 和 eGFR 与人体测量指数之间的关系,我们进行了线性回归分析。在完全调整的状态下,男女患者的 ACR 和 eGFR 与人体测量指标之间没有明显关系(P ˃.05):结论:高 WHtR 和 BMI 可能与男性慢性肾脏病有关。结论:高 WHtR 和 BMI 可能与男性慢性肾脏病有关,而 WHR 和 WC 与慢性肾脏病的发生无关。ACR和eGFR没有明显变化。 DOI: 10.52547/ijkd.7685.
{"title":"Association of Anthropometric Indices with Albumin to Creatinine Ratio and Glomerular Filtration Rate, as Indices of CKD: A Population-based Study.","authors":"Firouzeh Moinzadeh, Media Babahajiani, Marjan Mansourian, Hourinaz Taghvaee","doi":"10.52547/ijkd.7685","DOIUrl":"10.52547/ijkd.7685","url":null,"abstract":"<p><strong>Introduction: </strong>This study was an attempt to detect the relationship between chronic kidney disease (CKD) and anthropometric indices in presence of confounding variables.</p><p><strong>Methods: </strong>A cross-sectional study of 3375 participants was designed in Isfahan city. Waist-height ratio (WHtR), waist-hip ratio (WHR), body mass index (BMI) and waist circumference (WC) were measured. Participants were divided into CKD and non-CKD groups according to the calculated albumin to creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). Then, the groups were subdivided into sub-groups of high and normal anthropometric indices.</p><p><strong>Results: </strong>To evaluate CKD in relation to anthropometric indices, odds ratio was calculated; in the female group, no association was observed (P ˃ .05). However, in the male group high levels of WHtR and BMI were associated with CKD (P value of .002 and .015, respectively). To evaluate the association between ACR and eGFR with anthropometric indices linear regression analysis was performed. There was no significant relation between ACR and eGFR with anthropometric indices in both sexes in a fully adjusted state (P ˃ .05).</p><p><strong>Conclusion: </strong>High WHtR and BMI probably are associated with CKD in male. WHR and WC have no relation to the occurrence of CKD. There are no significant changes in regard to ACR and eGFR.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"1 1","pages":"27-35"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Outcome of Pauci-immune Crescentic Glomerulonephritis and Its Prognostic Factors; A single Center Case Series. 保济免疫新月体肾小球肾炎的预后及其预后因素;单中心病例系列。
IF 0.8 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.52547/ijkd.7545

Introduction: Pauci-immune crescentic glomerulonephritis (GN) is the most common cause of rapidly progressive GN in adults. The aim of this study was to determine the outcome of patients with pauci-immune crescentic GN and risk factors of the development of end-stage kidney disease (ESKD) in these patients.

Methods: This case series study was carried on 120 patients with pauci-immune crescentic GN biopsied in our center betwen 1998 and 2016. Inclusion criteria were age > 16 years, at least one crescentic glomerulus, maximally 1+ deposition of immunoglobulins and complement components at fluorescent microscopy, and at least 6 months follow-up. The main outcomes were ESKD and death.

Results: The study population included 120 patients with pauciimmune crescentic GN (mean age was 47 ± 17 years and 49.1% male). There was no significant difference in outcome between patients with diffuse or focal crescentic GN. Seventy-two patients (60%) developed ESKD and 31 patients (25.8%) died. The need for dialysis at admission, lower baseline hemoglobin and GFR and GFR at four months and high percentage of glomerulosclerosis and interstitial fibrosis had a significant relationship with low kidney survival (P < .05). The rate of ESKD was higher in patients who did not receive cyclophosphamide therapy, due to focal crescentic GN or high chronicity, compared to patients who received it (70.7 vs. 28.5%, P < .001).

Conclusion: In our study, a high percentage of patients with pauciimmune crescentic GN developed ESKD. Low first GFR and high chronicity in biopsy were associated with lower kidney survival. Failure to administer cyclophosphamide in seemingly limited or advanced cases, together with late referral may have led to poor prognosis.

导言:贫免疫性新月体肾小球肾炎(GN)是导致成人快速进展性肾小球肾炎的最常见原因。本研究旨在确定贫免疫性新月体肾小球肾炎患者的预后以及这些患者发展为终末期肾病(ESKD)的风险因素:本病例系列研究的对象是1998年至2016年间在本中心进行活检的120例贫免疫新月体GN患者。纳入标准为年龄大于16岁,至少有一个新月体肾小球,荧光显微镜下免疫球蛋白和补体成分沉积最大值为1+,随访至少6个月。主要结果为ESKD和死亡:研究对象包括120名低免疫新月体GN患者(平均年龄为47±17岁,49.1%为男性)。弥漫性或局灶性新月体 GN 患者的预后无明显差异。72名患者(60%)发展为ESKD,31名患者(25.8%)死亡。入院时需要透析、基线血红蛋白和 GFR 较低、4 个月时 GFR 较低、肾小球硬化和间质纤维化比例高与肾脏存活率低有显著关系(P < .05)。与接受环磷酰胺治疗的患者相比,因局灶性新月体 GN 或高度慢性化而未接受环磷酰胺治疗的患者 ESKD 发生率更高(70.7% 对 28.5%,P < .001):结论:在我们的研究中,高比例的低免疫新月体 GN 患者发展为 ESKD。首次肾小球滤过率低和活检慢性化程度高与肾脏存活率较低有关。在看似局限性或晚期病例中未使用环磷酰胺,加上转诊较晚,可能导致预后不良。 DOI: 10.52547/ijkd.7545.
{"title":"The Outcome of Pauci-immune Crescentic Glomerulonephritis and Its Prognostic Factors; A single Center Case Series.","authors":"","doi":"10.52547/ijkd.7545","DOIUrl":"10.52547/ijkd.7545","url":null,"abstract":"<p><strong>Introduction: </strong>Pauci-immune crescentic glomerulonephritis (GN) is the most common cause of rapidly progressive GN in adults. The aim of this study was to determine the outcome of patients with pauci-immune crescentic GN and risk factors of the development of end-stage kidney disease (ESKD) in these patients.</p><p><strong>Methods: </strong>This case series study was carried on 120 patients with pauci-immune crescentic GN biopsied in our center betwen 1998 and 2016. Inclusion criteria were age > 16 years, at least one crescentic glomerulus, maximally 1+ deposition of immunoglobulins and complement components at fluorescent microscopy, and at least 6 months follow-up. The main outcomes were ESKD and death.</p><p><strong>Results: </strong>The study population included 120 patients with pauciimmune crescentic GN (mean age was 47 ± 17 years and 49.1% male). There was no significant difference in outcome between patients with diffuse or focal crescentic GN. Seventy-two patients (60%) developed ESKD and 31 patients (25.8%) died. The need for dialysis at admission, lower baseline hemoglobin and GFR and GFR at four months and high percentage of glomerulosclerosis and interstitial fibrosis had a significant relationship with low kidney survival (P < .05). The rate of ESKD was higher in patients who did not receive cyclophosphamide therapy, due to focal crescentic GN or high chronicity, compared to patients who received it (70.7 vs. 28.5%, P < .001).</p><p><strong>Conclusion: </strong>In our study, a high percentage of patients with pauciimmune crescentic GN developed ESKD. Low first GFR and high chronicity in biopsy were associated with lower kidney survival. Failure to administer cyclophosphamide in seemingly limited or advanced cases, together with late referral may have led to poor prognosis.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"1 1","pages":"9-17"},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian journal of kidney diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1